Verastem reported $-17709000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US USD 4.6B 1.31B
AstraZeneca AZN:LN USD 1.25B 706M
Curis CRIS:US USD -12606000 2.46M
Cytokinetics CYTK:US USD -130687000 119.81M
Gilead Sciences GILD:US USD 2.84B 808M
Immunogen IMGN:US USD -77429000 16.38M
Laboratory Of America LH:US USD 469.4M 56.5M
Novartis NOVN:VX USD 2.17B 60M
Pfizer PFE:US USD 9.41B 2.69B
Roche Holding ROG:VX 11.55B 3.47B
Tg Therapeutics TGTX:US USD -34963000 3.98M
Verastem VSTM:US USD -17709000 3.69M
YTE INCY:US USD 138.38M 116.06M
Ziopharm Oncology ZIOP:US USD -8264000 969K